FDA Warning Letter — Exxon

Case 645876 — FEI 3024759471

The FDA took a Warning Letter action against Exxon on Nov 8, 2022 (Belmar, NJ). The action was issued by CTP and concerns tobacco products.

Action details

Facility
Exxon
Date
Nov 8, 2022
Fiscal Year
2023
Product Type
Tobacco
Center
CTP
Location
Belmar, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.